BioMarin Pharmaceutical Inc. ( BMRN) - Key Metrics
BMRN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $5.13 | $0.23 | $0.87 | $0.72 |
| 2026Q1 | $3.98 | $0.55 | $1.15 | $1.04 |
| 2025Q4 | $4.56 | -$0.24 | $0.52 | $0.31 |
| 2025Q3 | $4.04 | -$0.16 | $1.92 | $1.74 |
| 2025Q2 | $4.31 | $1.26 | $0.97 | $0.88 |
BMRN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 62.20 |
| 2026Q1 | 0% | 25.68 |
| 2025Q4 | 0% | -61.91 |
| 2025Q3 | 0% | -84.63 |
| 2025Q2 | 0% | 10.99 |
BMRN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.26% | 0% |
| 2026Q1 | 1.84% | 0% |
| 2025Q4 | 0.52% | 0% |
| 2025Q3 | 3.22% | 0% |
| 2025Q2 | 1.60% | 0% |
BMRN
Price: $67.36
52 week price:
Earnings Per Share: 0.37 USD
P/E Ratio: 189.84
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: 11.0 millionMarket Capitalization: 13.6 billion